Please login to the form below

Not currently logged in
Email:
Password:

Kremers Urban

This page shows the latest Kremers Urban news and features for those working in and with pharma, biotech and healthcare.

UCB boosted by core medicines growth

UCB boosted by core medicines growth

The firm had been poised to sell its Kremers Urban generics business in order to focus almost exclusively on patented medicines, but the $1.5bn sale fell through in December after ... The Belgian pharma firm remains optimistic about its overall finances,

Latest news

  • UCB's $1.53bn generics sale falls through UCB's $1.53bn generics sale falls through

    Advent and Avista Capita back away from bid to acquire Kremers Urban due to unanticipated conflict in timing.  . ... Kremers Urban has already said it intends to perform the requested additional study.

  • UCB to sell its US generics business for $1.5bn UCB to sell its US generics business for $1.5bn

    Advent International and Avista Capital Partners will take control of Kremers Urban Pharmaceuticals. ... We thank our Kremers Urban colleagues for the excellent performance they have delivered.

  • Novartis said to want out of Indian vaccines venture Novartis said to want out of Indian vaccines venture

    It also forged two new collaborations for generic pharmaceutical products signed towards the end of last year with UCB subsidiary Kremers Urban Pharmaceuticals and Osmotica Pharmaceutical.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...
MIT reveals new pill to deliver insulin
A new MIT research project, sponsored by Novo Nordisk, is aiming to deliver insulin orally with a pill that releases medicine in the stomach lining. Dina Patel interviews the team...
Fearless Girl cover
25 Women Leaders in UK Healthcare
Women trailblazers helping to shape the future of healthcare (Part 1)...

Infographics